ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

[The value of plasma EBV-DNA testing in high-risk group of nasopharyngeal carcinoma in the nasal endoscopy].

He X F; Yu X; Ji M F; Fu M Y
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2017-5-20DOI: 10.13201/j.issn.1001-1781.2017.10.008
5阅读
引用收藏
分享

摘要

Objective:The aim of this study is to evaluate the level of plasma EBV DNA and nasal endoscopy in high risk population of nasopharyngeal carcinoma, and to explore the value of EBV DNA testing in nasal endoscopy. Method:The nasopharyngeal carcinoma was screened in High-incidence Area of Zhongshan City. EBV antibody was detected by ELISA, and 427 patients with high risk of nasopharyngeal carcinoma were identified. In the high risk population the plasma EBV-DNA was measured using Fluorescent quantitative PCR, and all patients were used nasal endoscopy in the first two years. The application value of EBV DNA and nasopharyngeal endoscopic biopsy were analyzed. Result:There were 427 NPC high risk population in first screening. The rates of nasopharyngeal biopsy in EBV DNA positive and EBV DNA negative population were 90.2% (55/61) and 13.9% (51/366), respectively. The rate of NPC nasopharyngeal biopsy in EBV DNA positive population was higher than that in EBV DNA negative population (P<0.01). The rate of NPC detection in EBV DNA positive group (60.7%) was higher than that (3.3%) in EBV DNA negative population (P<0.01). In first year follow up, there were 286 NPC high risk population. The rates of nasopharyngeal biopsy in EBV DNA positive and EBV DNA negative population were 91.2% (31/34) and 11.9% (30/252), respectively. The rate of NPC nasopharyngeal biopsy in EBV DNA positive population was higher than that in EBV DNA negative population (P<0.01). The rate of NPC detection in EBV DNA positive group (17.6%) was higher than that (1.6%) in EBV DNA negative population (P<0.01). The positive predicative value of serological risk assessment was 8.3% (59/713), but for NPC high risk group, adding quantitative analysis of plasma EBV DNA, the positive predicative value was 45.3% (43/95). The early diagnosis rates in EBV DNA positive and EBV DNA negative population were 79.1% (34/43) and 93.8% (15/16), respectively. There was no significant difference in early diagnosis rates in two groups (P>0.05). Conclusion:The positive rate of plasma EBV DNA in high risk group of nasopharyngeal carcinoma may be helpful for nasal endoscopic nasopharyngeal biopsy, which can greatly improve the positive predictive value of high risk population of nasopharyngeal carcinoma. For NPC high risk population, Therefore, EBV DNA positive population are the focus for NPC screening.

学科与关键词

关键词
EBV-DNAhigh-risk populationnasal endoscopynasopharyngeal carcinomascreening
相关
加载中…
  • Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
    Chan K C Allen; Woo John K S; King Ann; Zee Benny C Y; Lam W K Jacky; Chan Stephen L; Chu Sam W I; Mak Constance; Tse Irene O L; Leung Samantha Y M; Chan Gloria; Hui Edwin P; Ma Brigette B Y; Chiu Rossa W K; Leung Sing Fai; van Hasselt Andrew C; Chan Anthony T C; Lo Y M DennisN Engl J Med, 2017, 377(6): 513-522.
  • Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern China
    He, Qiao; Zhou, Yi; Zhou, Jie; Zhao, Dan; Li, Luona; Li, Xianbing; Huang, Yecai; Wang, Qiuju; Zou, Haiming; Zhang, Kaijiong; Li, Yuping; Wang, Zuo; Deng, Yao; Meng, Fanping*; Ying, Binwu*; Yang, Mu*; Wang, Dongsheng*Clinica Chimica Acta, 2023, 541: 117244.被引 3
  • Clinical significance of EBV-DNA in patients with Advanced nasopharyngeal carcinoma
    Mai Hui; Ma Huimin; Yao Weiqiong2011.
查看全部 →

发表信息

论文状态
公开发表
期刊
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
发表日期
2017-05-20
卷期
第 31 卷, 第 10 期
页码
770-773
DOI
10.13201/j.issn.1001-1781.2017.10.008
成果收录
PUBMED

作者

  • H

    He X F (第一作者)

  • Y

    Yu X

查看全部 4 位作者收起作者
  • J

    Ji M F

  • F

    Fu M Y

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417